Pages that link to "Q36018288"
Jump to navigation
Jump to search
The following pages link to Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience (Q36018288):
Displaying 10 items.
- Biologics in dermatology: an integrated review (Q27004638) (← links)
- Evidence for the use of intravenous immunoglobulins--a review of the literature (Q33385332) (← links)
- Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders (Q36602778) (← links)
- Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology (Q36711702) (← links)
- Diagnosis and treatment of urticaria and angioedema: a worldwide perspective (Q36834774) (← links)
- Novel therapies for pemphigus vulgaris: an overview (Q37598882) (← links)
- Treatment of refractory chronic urticaria: current and future therapeutic options (Q38148494) (← links)
- Current challenges and controversies in the management of chronic spontaneous urticaria (Q38547047) (← links)
- Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma (Q84039451) (← links)
- Linear Immunoglobulin A Bullous Disease of Childhood Responsive to Intravenous Immunoglobulin Monotherapy (Q84925977) (← links)